What is ASBP stock price today?

ASBP (Aspire Biopharma Holdings Inc) stock is trading at $5.41 as of the latest market data. Stock prices update in real-time during market hours (9:30 AM - 4:00 PM ET).

Is ASBP stock going up or down today?

ASBP stock price movements are influenced by market conditions, news, earnings reports, and investor sentiment. Check our live dashboard for real-time price changes and technical indicators.

Should I buy ASBP stock now?

The decision to buy ASBP depends on your investment strategy, risk tolerance, and financial goals. Our AI analysis evaluates fundamentals, valuation metrics, growth prospects, and market conditions to help inform your decision.

Is ASBP a buy, hold, or sell right now?

Our AI-powered analysis provides buy/hold/sell recommendations for ASBP based on multiple factors including valuation, growth metrics, technical indicators, and analyst consensus. Visit our dashboard for the latest recommendation.

Is ASBP stock overvalued or undervalued?

Use our DCF valuation calculator to determine if ASBP is overvalued or undervalued based on fundamental analysis and future cash flow projections.

What is ASBP's P/E ratio?

P/E ratio data for ASBP will be available after the company reports earnings. Visit our dashboard for the latest financial metrics.

What is ASBP's market cap?

ASBP (Aspire Biopharma Holdings Inc) has a market capitalization of $0.01 billion, making it a small-cap stock.

What is ASBP's price to book ratio?

ASBP trades at a price-to-book (P/B) ratio of 1.81, which compares the stock price to the company's book value per share. A P/B below 1.0 may indicate undervaluation, while above 3.0 may suggest premium pricing.

Does ASBP pay dividends?

ASBP does not currently pay dividends. Many growth companies reinvest profits into the business rather than paying dividends.

What is ASBP's dividend yield?

ASBP does not currently pay dividends or dividend data is not available. Check our dashboard for the latest information.

Is ASBP stock a good long-term investment?

ASBP's long-term investment potential depends on sustainable competitive advantages, revenue growth, profitability, management quality, and industry dynamics. Our AI analysis evaluates these factors to assess long-term prospects.

What is ASBP's revenue growth rate?

Revenue growth data for ASBP is available on our dashboard with detailed financial statement analysis.

Profitability metrics for ASBP are available on our dashboard with complete income statement analysis.

What are the risks of investing in ASBP?

Key risks for ASBP include market volatility, competitive pressures, regulatory changes, economic conditions, execution risks, and company-specific factors. Our AI analysis identifies material risks and their potential impact on valuation.

How does ASBP compare to its competitors?

Compare ASBP to industry peers on our dashboard using metrics like P/E ratio, revenue growth, profit margins, market share, and valuation multiples. Competitive analysis helps contextualize ASBP's performance and positioning.

What is ASBP's stock price target for 2026?

Our AI model provides price targets for ASBP based on fundamental analysis: Bull case $7.03 (+30%), Base case $6.22 (+15%), Bear case $4.87 (-10%). Visit our prediction page for detailed forecasts.

What do analysts say about ASBP?

Wall Street analysts provide ratings (buy/hold/sell) and price targets for ASBP. Our dashboard aggregates analyst consensus, target prices, and recent upgrades/downgrades to help you understand professional sentiment.

When is ASBP's next earnings report?

ASBP reports earnings quarterly. Check our dashboard for the upcoming earnings date, analyst estimates for revenue and EPS, and historical earnings performance. Earnings reports often drive significant stock price movements.

ASBP - Aspire Biopharma Holdings Inc

NYSE * Health Care * Biotechnology

$5.41

$-0.18 (-3.22%)

About Aspire Biopharma Holdings Inc

Aspire Biopharma Holdings, Inc., an early-stage biopharmaceutical company, develops and markets disruptive technology for novel sublingual delivery mechanisms in the United States. It offers sublingual aspirin product that is a soluble, PH neutral, and fast acting aspirin, which addresses cardiology emergencies and pain management. The company is also developing formulations for sublingually administered products, such as melatonin sleep-aid product; vitamins D, E, and K; testosterone; and semaglutide product. In addition, it is developing formulations for anti-nausea products, anti-psychotic products, ED drugs, seizure medication, and other classes of drugs through sublingual administration; and caffeine products, such as a formula for a single dose sublingual pre-workout supplement. The company was founded in 2021 and is headquartered in Estero, Florida.

ASBP Key Statistics

Market Cap

$7.01M

P/B Ratio

1.81

EPS

$-7.09

How ASBP Compares to Peers

ASBP is the smallest among peers, which may offer higher growth potential

P/E Rank

N/A

of 5

Margin Rank

N/A

of 5

Growth Rank

N/A

of 5

Size Rank

of 6

Company	Market Cap	P/E	Growth	Margin	Compare
ASBP(This stock)	$7.01M	N/A	0%	0.0%	-
AMGNAmgen Inc	$183.12B	23.6	0%	0.2%	vs AMGN
GILDGilead Sciences	$166.82B	18.3	0%	0.3%	vs GILD
VRTXVertex Pharmaceuticals	$110.28B	25.8	0%	0.4%	vs VRTX
REGNRegeneron Pharmaceuticals	$66.98B	15.6	0%	0.3%	vs REGN
BIIBBiogen Inc	$28.61B	20.8	0%	0.1%	vs BIIB

Aspire Biopharma Holdings Inc Company Information

Headquarters: Puerto Rico
Website: aspirebiolabs.com
Sector: Health Care
Industry: Biotechnology

Data Updated: May 25, 2026 at 1:04 AM EDT

Ready to invest in ASBP?

Commission-free trading available. Affiliate links.

Upcoming Events for ASBP

Dashboard

Enter a ticker to analyze